RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...
Recent trends in cancer distribution and survival outcomes among adolescent and young adult patients: A national data analysis.
A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...
Viome, maker of at-home test kits for gut, immune and cellular health, has received FDA breakthrough device designation for its mRNA analysis technology and artificial intelligence platform that ...
A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA. A research team led by Professor Won Jong Kim from the Department of Chemistry at POSTECH, ...
A study led by researchers from RMIT University and the Doherty Institute has provided the first detailed analysis of how mRNA vaccines circulate and break down in the human bloodstream. The research ...
Mast interviewed more than two dozen former and current Moderna employees, along with analysts, rival executives, investors, and experts in mRNA and vaccines to understand how the company arrived at ...
Outcome of chemo-immunotherapy for extensive-stage small-cell lung cancer according to potential clinical trial eligibility: 3-year outcomes from prospective cohort study. Tifcemalimab combined with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback